Literature DB >> 23103000

Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.

Jean Perentes1, Sabina Bopp, Thorsten Krueger, Michel Gonzalez, Pierre-Yves Jayet, Alban Lovis, Oscar Matzinger, Christiane Ruffieux, Hans-Beat Ris, Igor Letovanec, Solange Peters.   

Abstract

BACKGROUND: Induction radiochemotherapy, followed by resection, for T4 non-small cell lung cancer, has shown promising long-term survival but may be associated with increased postoperative morbidity and death, depending on patient selection. Here, we determined the effect of induction radiochemotherapy on pulmonary function and whether postinduction pulmonary function changes predict hospital morbidity and death and long-term survival.
METHODS: A consecutive prospective cohort of 72 patients with T4 N0-2 M0 non-small cell lung cancer managed by radiochemotherapy, followed by resection, is reported. All patients underwent thoracoabdominal computed tomography or fusion positron emission tomography-computed tomography, brain imaging, mediastinoscopy, echocardiography, ventilation-perfusion scintigraphy, and pulmonary function testing before and after induction therapy. Resection was performed if the postoperative forced expiratory volume in 1 second and diffusion capacity of the lung for carbon monoxide exceeded 30% predicted and if the postoperative maximum oxygen consumption exceeded 10 mL/kg/min.
RESULTS: The postoperative 90-day mortality rate was 8% (lobectomy, 2%; pneumonectomy, 21%; p=0.01). All deaths after pneumonectomy occurred after right-sided procedures. The 3-year and 5-year survival was 50% (95% confidence interval, 36% to 62%) and 45% (95% confidence interval, 31% to 57%) and was significantly associated with completeness of resection (p=0.004) and resection type (pneumonectomy vs lobectomy, p=0.01). There was no correlation between postinduction pulmonary function changes and postoperative morbidity or death or long-term survival in patients managed by lobectomy or pneumonectomy.
CONCLUSIONS: In properly selected patients with T4 N0-2 M0 non-small cell lung cancer, resection after induction radiochemotherapy can be performed with a reasonable postoperative mortality rate and long-term survival, provided the resection is complete and a right-sided pneumonectomy is avoided. Postinduction pulmonary function changes did not correlate with postoperative morbidity or death or with long-term outcome.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23103000     DOI: 10.1016/j.athoracsur.2012.08.054

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment.

Authors:  Nika Guberina; Christoph Pöttgen; Martin Schuler; Maja Guberina; Georgios Stamatis; Till Plönes; Martin Metzenmacher; Dirk Theegarten; Thomas Gauler; Kaid Darwiche; Clemens Aigner; Wilfried E E Eberhardt; Martin Stuschke
Journal:  Radiat Oncol       Date:  2022-07-16       Impact factor: 4.309

Review 2.  Long-term pulmonary function after major lung resection.

Authors:  Kazuhiro Ueda; Masataro Hayashi; Nobuyuki Tanaka; Toshiki Tanaka; Kimikazu Hamano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-11-23

3.  Changes in Forced Expiratory Volume in 1 Second after Anatomical Lung Resection according to the Number of Segments.

Authors:  Sun-Geun Lee; Seung Hyong Lee; Sang-Ho Cho; Jae Won Song; Chang-Mo Oh; Dae Hyun Kim
Journal:  J Chest Surg       Date:  2021-12-05

4.  Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function.

Authors:  Takahiro Mimae; Yoshihiro Miyata; Takashi Kumada; Yoshinori Handa; Yasuhiro Tsutani; Morihito Okada
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02

Review 5.  Extracorporeal support for pulmonary resection: current indications and results.

Authors:  Petra Rosskopfova; Jean Yannis Perentes; Hans-Beat Ris; Fabrizio Gronchi; Thorsten Krueger; Michel Gonzalez
Journal:  World J Surg Oncol       Date:  2016-02-02       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.